SIDEWINDER THERAPEUTICS
LIVE

Serial Number

98307987

Owner

Sidewinder Therapeutics, Inc.

Attorney

Aaron D. Hendelman

Filing Date

Dec 11, 2023

Add to watchlist:

No watchlists yet
View on USPTO

SIDEWINDER THERAPEUTICS Trademark

Serial Number: 98307987

SIDEWINDER THERAPEUTICS is a trademark filed by Sidewinder Therapeutics, Inc. on December 11, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Sidewinder Therapeutics, Inc.

9880 Campus Point Drive, Suite 360
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

December 11, 2023

Registration Date

Not Registered

Published for Opposition

February 11, 2025

Goods & Services

Pharmaceutical and biological preparations for the treatment and prevention of diseases in humans, namely, cardiovascular disease, epilepsy, mitochondrial disease, central nervous system disease, infectious disease, acute respiratory disease, and rare autoimmune, viral and infectious diseases; pharmaceutical preparations, namely, a drug formulation for use in angiology, cardiology, endocrinology, gastroenterology, geriatrics, hematology, hepatology, nephrology, neurology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, ophthalmology, oncology, infectiology, and psychiatry; pharmaceutical preparations, namely, a drug formulation for use in pediatrics, geriatrics, emergency psychiatry, family psychiatry, and psychiatry; pharmaceutical preparations for the treatment of infectious and hereditary diseases; pharmaceutical preparations for the treatment or prevention of diseases, disorders and conditions associated with the muscular system, the skeletal system, the cardiovascular system, the central nervous system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, and the integumentary system; pharmaceutical preparations for the treatment or prevention of muscle loss, metabolic conditions and diseases, gastrointestinal conditions and diseases, neurological conditions and diseases, cancer, osteoporosis, inflammatory conditions and diseases, genetic conditions and diseases, muscle diseases and disorders, hepatic conditions and diseases, fibrosis, malnutrition, atrophic diseases and conditions, epilepsy, sarcopenia, myopathies, neuropathies, neurodegenerative diseases, traumatic brain injury, concussions, movement disorders, dystrophies, anemias, and orphan diseases; pharmaceutical and biological preparations, namely, precision therapeutics for the treatment or prevention of diseases, disorders and conditions associated with the muscular system, the skeletal system, the cardiovascular system, the central nervous system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, and the integumentary system; pharmaceutical and biological preparations, namely, large molecule precision therapeutics for the treatment or prevention of diseases, disorders and conditions associated with the muscular system, the skeletal system, the cardiovascular system, the central nervous system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, and the integumentary system

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 2, 2026 EXRA
SOU EXTENSION 2 GRANTED
Apr 2, 2026 EX2G
SOU EXTENSION 2 FILED
Apr 1, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 1, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 25, 2025 EXRA
SOU EXTENSION 1 GRANTED
Apr 25, 2025 EX1G
SOU EXTENSION 1 FILED
Apr 24, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 24, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 8, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 21, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 17, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 17, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 17, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 7, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 7, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 5, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 5, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 5, 2024 CNRT
ASSIGNED TO EXAMINER
Jul 10, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 11, 2024 NWOS
NEW APPLICATION ENTERED
Dec 11, 2023 NWAP